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Systematic Techniques to Enhance
rEtention in Randomised controlled trials:
the STEER study protocol
Katie Gillies1* , Peter Bower2, Jim Elliott1, Graeme MacLennan3, Rumana S. N. Newlands4, Margaret Ogden1,
Shaun P. Treweek1, Mary Wells5, Miles D. Witham6, Bridget Young7 and Jill J. Francis8
Abstract
Background: Non-retention of participants seriously affects the credibility of clinical trial results and significantly reduces
the potential of a trial to influence clinical practice. Non-retention can be defined as instances where participants leave
the study prematurely. Examples include withdrawal of consent and loss to follow-up and thus outcome data cannot be
obtained. The majority of existing interventions targeting retention fail to describe any theoretical basis for the observed
improvement, or lack of improvement. Moreover, most of these interventions lack involvement of participants in their
conception and/or design, raising questions about their relevance and acceptability. Many of the causes of non-retention
involve people performing a behaviour (e.g. not returning a questionnaire). Behaviour change is difficult, and the
importance of a strong theoretical basis for interventions that aim to change behaviour is increasingly recognised. This
research aims to develop and pilot theoretically informed, participant-centred, evidence-based behaviour change
interventions to improve retention in trials.
Methods: This research will generate data through semi-structured interviews on stakeholders’ perspectives of
the reasons for trial non-retention. It will identify perceived barriers and enablers to trial retention using the Theoretical
Domains Framework. The intervention development work will involve identification of behaviour change techniques,
using recognised methodology, and co-production of retention interventions through discussion groups with
end-users. An evaluation of intervention acceptability and feasibility will be conducted in focus groups. Finally,
a ready-to-use evaluation framework to deploy in Studies Within A Trial as well as an explanatory retention
framework will be developed for identifying and tackling modifiable issues to improve trial retention.
Discussion: We believe this to be one of the first studies to apply a theoretical lens to the development of interventions
to improve trial retention that have been informed by, and are embedded within, participants’ experiential accounts. By
developing and identifying priority interventions this study will support efforts to reduce research waste.
Keywords: Trials, Retention, Non-retention, Dropout, Theory, Intervention, Interviews
Background
Randomised controlled trials are the cornerstone of
evidence-based healthcare as they provide unbiased
estimates of the benefits and harms of treatment if
conducted rigorously [1]. It is common for many trial
participants (sometimes more than 20%) to drop out
before the trial finishes [2]. Moreover, 50% of trials have
loss to follow-up of over 11% [2]. Dropout is defined
here as non-retention as per the ‘Standard Protocol
Items: Recommendations for Interventional Trials’
(SPIRIT) guidelines. SPIRIT defines non-retention as
‘instances where participants are prematurely “off-study”
(i.e., consent withdrawn or lost to follow-up) and thus
outcome data cannot be obtained from them’. Non-
retention, therefore, seriously affects the credibility of
trial results and significantly affects the potential of a
trial to influence clinical practice [3]. Recent estimates
have shown that the results of around half of all clinical
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trials could have been overturned if the outcomes from
the non-retainers were known [4]. In other words,
healthcare systems may not be delivering the best
possible care because trial dropout has undermined the
evidence upon which that care choice is based. Our
research aims to develop and test participant-centred,
theoretically informed interventions to reduce non-
retention in trials using insights from behaviour change
theory. These interventions have the potential to improve
the evidence base on which clinical care treatment choices
are made.
Much current research on interventions to minimise
non-retention is not based on theory or formal evidence
[5]. Yet many aspects of non-retention involve performing
a behaviour (e.g. returning a questionnaire) and may be
influenced and modified by a range of factors (e.g. attend-
ing a follow-up clinic may be influenced by access to
transport). The Cochrane review on trial retention strategies
provides little guidance to improve retention beyond
offering money to return questionnaires; there were no
included interventions designed to target the reasons why
people may drop out of trials [5]. Without effective ways of
reducing non-retention, trials currently have to build in
inflated sample sizes at baseline to allow for trial partici-
pants who will not be retained. The average cost of a
clinical trial in the UK is about £8500 per participant [6]; so
recruiting extra participants to account for non-retention,
therefore, imposes significant costs on trial funders – costs
which are not then available to support additional trials.
Not surprisingly, finding evidence-based ways to reduce
non-retention has been identified as one of the top three
research priorities by the UK clinical trial community [7].
The majority of existing interventions targeting retention
fail to describe any theoretical, and hence generalisable,
basis for the observed improvement, or lack of improve-
ment [5]. Moreover, most of these interventions lack
involvement of participants in their conception and/or
design, raising questions about their relevance and accept-
ability [5]. Many of the causes of non-retention involve
people performing, or not performing, an action such as
returning a questionnaire; in other words, performing a
behaviour. Behaviour change is difficult, and the importance
of a strong theoretical basis for interventions that aim to
change behaviour is increasingly recognised [8]. Framing
intervention design with reference to behavioural theory of-
fers the possibility of a rationale for developing targeted
interventions to support retention and, moreover, provides
the basis for a widely applicable methodology for designing
such interventions [8]. Evidence from one trial evaluating a
theoretically informed letter to target return of trial ques-
tionnaires showed a 6% improvement in response rates in
the intervention group [9]. However, the perspectives of
people in the target group (i.e. potential non-retainers) were
not incorporated into the design of the intervention
suggesting that the potential benefit may be even larger
were these perspectives taken into consideration during
design. The research described in this protocol will
combine the use of behavioural theory and participant
perspectives to underpin retention intervention develop-
ment and directly address this evidence gap.
Before developing interventions to change behaviour it
is important to define the behaviour of interest. For the
purposes of the research described in this protocol the
behaviour of interest is non-retention relating to failure
to collect trial primary outcome data. To define this
further, ‘trial non-retention’ encompasses several specific
aspects of behaviour, namely:
 Failure to return questionnaire data (where mode of
delivery/response may vary from postal, email or
others)
 Failure to attend follow-up clinics as part of trial
follow-up procedures
 Participant request for no further follow-up
Applying the Target, Action, Context, Time, Actor
(TACTA) framework to the behaviour, the behaviour
would be specified as follows [10]:
 Target: all trial participants
 Action: e.g. return of questionnaire or attendance at
clinic
 Context: e.g. at home or in clinic
 Time: e.g. dependent on trial follow-up time points
 Actor: e.g. trial study staff or trial site staff or
clinical staff
This research will not be considering non-adherence
to trial interventions or failure to correctly complete
questionnaires (e.g. return of questionnaire but missing
primary outcome data) as these are outside the scope of
this work. The reason for not including these behaviours
in this research is that the nature of the underlying
behaviour is likely demonstrably different to that of non-
retention and, therefore, would require a different focus
for intervention development.
This protocol details research that aims to develop
theoretically informed, participant-centred, retention
interventions (see Fig. 1) The structure of the work is
based on the methodological approach recommended by
the Medical Research Council (MRC) guidance for
developing and evaluating complex interventions [11].
The MRC guidance provides a systematic approach to
inform: intervention development; feasibility and piloting;
evaluation (including process evaluation) and implementa-
tion. The research described in this protocol explicitly
addresses intervention development, feasibility and piloting,
and plans for the evaluation components of the guidance
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but will also explore initial perspectives on implementation.
The project team will work with a range of stakeholders
(defined as trial participants, and trial staff with direct
insights about why participants fail to be retained, e.g.
research nurses, trial managers, data coordinators) across
various aspects of the project. Alongside the MRC frame-
work for developing and evaluating complex interventions,
the overarching methodology for the study will use an estab-
lished theoretical framework (Theoretical Domains Frame-
work, TDF) to inform the development of targeted retention
interventions [12]. The TDF is a comprehensive framework
that proposes 14 behaviour domains that may influence
behaviour (e.g. knowledge, behavioural regulation, emotion).
Priority domains are ascertained and context-specific
barriers within each domain are identified, often by coding
stakeholder interview data to identify barriers that are
important to stakeholders, which are then targeted when
developing behavioural interventions [13]. Key behaviour
change techniques (BCTs) can be incorporated into the
development of interventions to specifically target theoret-
ical constructs. BCTs are defined as the smallest ‘active
ingredient’ of an intervention. In other words, techniques
that cannot be reduced further to smaller components, e.g.
goal setting or self-monitoring of behaviour, and they can be
used alone or in combination with other BCTs [14, 15]. The
BCT taxonomy, generated through international expert con-
sensus, contains 93 techniques that can be applied to behav-
iour change interventions to systematically describe, review
and replicate core content and can also be used to develop
new, complex, behaviour change interventions [14, 15].
Whilst some retention challenges will be common across
trials, it is likely that others will be unique to particular trial
problems and trial contexts. For the purposes of this project,
we are defining context as ‘the key features of the environ-
ment in which the work is immersed and which are inter-
preted as meaningful to the success, failure and unexpected
consequences of the trial, as well as the relationship of these
to the stakeholders’ (adapted from Ogrinc et al.) [16]. To
maximise transferability of findings from this research, trial
context will be limited to Phase III pragmatic effectiveness
randomised controlled trials (RCTs) that include adults who
have capacity to consent for themselves in non-emergency
settings. This research aims to deliver both (1) potential
solutions for common retention challenges and (2) a
generalisable method (i.e. development of behaviourally
focussed retention interventions) for identifying and
managing challenges unique to a given trial. The impact of
this strategy will be to reduce the research waste associated
with the common problem of substantial trial non-retention.
Aim
The overall aim of the study is to develop and pilot theoret-
ically informed, participant-centred, evidence-based behav-
iour change interventions to improve retention in trials.
Research objectives (RO)
1. Identify the problem (identify stakeholders’ views
and experiences of non-retention to determine ‘who
needs to do what differently?’)
Fig. 1 STEER protocol overview
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2. Assess the problem (use a theoretical framework to
identify which barriers and enablers to retention in
trials need to be targeted)
3. Form possible solutions (which behaviour change
techniques could overcome the modifiable barriers
and enhance the enablers of trial retention and how
best could these techniques be presented); and
4. Evaluate feasibility and acceptability of the selected
interventions (explore the feasibility and
acceptability of potential interventions from the
perspective of stakeholders and how retention
interventions can be implemented in new and
ongoing trials).
Methods
Identifying and assessing the problem (RO1 and RO2)
Research objectives 1 and 2 will generate data on stake-
holders’ perspectives on the reasons for trial non-
retention and identify perceived barriers and enablers to
trial retention. Exploring these issues across a range of
trials will allow us to draw conclusions about the
barriers and enablers of retention likely to apply across
trials as well as those that are more context specific.
Study design
We will conduct semi-structured interviews to explore
participants’ experiences of the trial, non-retention, what
could have been done to retain them or what helped them
to continue and what behavioural barriers and enablers
were experienced. To achieve this, adult participants who
have dropped out or considered dropping out from on-
going trials (identified from Aberdeen, Dundee and
Manchester clinical trial unit portfolios) will be invited to
participate. Previous published research (including work
from our team) has successfully engaged people who drop
out from trials in qualitative research [17–21].
In addition, trial staff will be interviewed to explore
perceptions about why participants fail to be retained
and what helped to keep others engaged in a specific
trial, but also explore more generally what strategies or
factors contribute to ‘good’ retention in trials. Interview
guides will also investigate which behaviours (actions
and non-actions) influenced trial non-retention.
Participant sampling and recruitment
Host trials We will select trials with poor retention (e.g.
those with more than 15% missing primary outcome
data) from the portfolios of the trials units involved in
this proposal. As much as possible, trials will be selected
purposively to maximise variability in trial intervention
and population (e.g. young vs old, multimorbidity vs
little comorbidity, acute vs chronic conditions, etc.) such
that influence of context is maximised in the sampling
frame and data generated takes this into account. Specific-
ally, we will sample trials for inclusion based on early vs
late non-retention (which will be defined for each trial
included in the sample but will likely be linked to data
collection time points) and the potential influence of trial
burden (i.e. how much ‘work’ is involved for the partici-
pant, e.g. through number of visits or questionnaires
required to collect follow up data). Moreover, we will also
consider ‘trial team expertise’. We will use the number of
years of trial experience within the trial team (both for
clinical and non-clinical team members) as factors to
inform sampling. Wherever possible, included trials will be
in the active follow-up phase such that the non-retention
event is closely situated to the time of interview (i.e. no
more than 3 months from attempt of last follow-up).
Sampling of participants We will develop a purposive
sampling strategy to identify trial participants who are
not retained, or who deliberated about non-retention
(identified by contacting retained participants or those
participants who have missed one or more data collection
time points but who subsequently re-engaged), from the
trials identified above. We will maximise efforts to ensure
that the participants invited to take part in this study are
representative of those who are not retained in trials.
Specifically, efforts will be made to maximise the diversity
of the sample by identifying and inviting participants from
all trial arms and across a range of socio-demographic
backgrounds. In addition to trial participants, we will iden-
tify trial staff (e.g. research nurses, trial managers, data
coordinators) associated with the poorly retaining trials
and invite them for interview. Through purposive sampling
a diverse range of participants (both trial participants and
staff) will be included. Our aim is to recruit participants
with a wide variety of trial experience and diverse perspec-
tives on features that are important to people when
deciding whether or not to be retained within an RCT.
Recruitment of participants We will send an invitation
letter and Participant Information Leaflet to prospective
participants, both of which will be informed for content
by our patient and public involvement (PPI) members,
by post or by email, depending on the contact details
held for participants. All trial staff will be contacted by
email. Interested parties will be asked to contact the
STEER research fellow (RN) directly to arrange a
convenient time to conduct the interview. Two attempts
will be made to engage with potential participants after
which point no further contact will be made. Before the
interview commences the researcher (RN) will obtain
verbal informed consent from participants. The interviews
will be conducted over the telephone so as to allow inclu-
sion of participants across a wide geographic area but,
where possible, face-to-face interviews will be offered.
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We will conduct approximately 45 interviews (approxi-
mately six participants and three staff (e.g. research
nurses, trial managers, data coordinators) from each of
five on-going trials) as per sampling informed by similar
studies [21]. Recruitment to the interviews will be termi-
nated if no new opinions emerge from the data, and this
will be defined as no additional material appearing from
three consecutive interviews [22]. To achieve the required
interview sample it is likely that we will need to invite 30
non-retainers from each trial to allow for an approximate
80% non-response.
Data collection
The interview topic guides are informed by the Theoretical
Domains Framework (TDF). Whilst the interview guide is
informed by the TDF, the interviews will start by exploring
personal narratives for trial non-retention and then follow
questions based on the TDF. These narratives may identify
reasons that do not have a behavioural component and are
not be appropriate for intervention, e.g. the direct impact
of bereavement. We will develop and refine a topic guide
by pilot testing and discussion with the research team
(including PPI representatives who will have considerable
input into the phrasing of the questions) and trial stake-
holders to ensure its comprehensibility, acceptability and
theoretical robustness. The number of questions in the
interview topic guide will vary for each domain and we will
include prompts to address specific constructs within the
domains [13]. The interviews will last approximately 20–
40 min and will be audio-recorded. A second researcher
will listen to the recordings of the first two interviews to
check fidelity of the use of the topic guide.
Data analysis
Transcribed and anonymised interview transcripts will
be imported into NVivo qualitative analysis software
version 11 (QSR International, Doncaster, VIC, Australia,
2017) and analysed first through an inductive approach.
We will code and compare interview data through a
process of constant comparison to provide a summary of
the key points that trial participants and trial staff consider
important in this context [23]. The themes and the associ-
ated data identified from the transcripts will be reviewed
by a second member of the project team. We will analyse
each group in parallel, but we will also conduct within-
and across-group analyses to explore areas of convergence
and areas of divergence. A directed content analysis
approach will then inform the second deductive stage of
analysis to identify behaviours and interactions that are
relevant for retention and can be targeted using theoretic-
ally informed interventions [24]. Two researchers will
code the first three transcripts concurrently to develop a
coding strategy, which will be informed by the TDF and
the initial inductive analysis. Subsequent transcripts will
be coded by one researcher and a random 10% sample will
be independently double coded. Inter-rater reliability for
coding will be assessed using a Cohen’s kappa calculation
with a kappa value of 0.75 or more representing high
agreement [25]. Any disagreements in coding will be
resolved by a third independent coder, appropriate
revisions to the coding strategy implemented, followed by
double coding a further 10% until reliability on coding (a
kappa of 0.75 or greater) is achieved. We will code the ver-
batim data to the specific theoretical domains of the TDF
using the coding strategy and assessments of their relative
importance identified through frequency ranking [26].
Domains will be considered to be ‘relevant’ if frequently
mentioned responses determined by scree plot indicate
the potential to affect the target behaviour, i.e. trial reten-
tion. Also, if domains are low in frequency (< 50%) but
codes identify opportunity (variation) to target for change
in practice they will also be considered for behaviour
change technique (BCT) mapping. We will analyse data
on an on-going basis until the target sample size of 45 is
achieved or no new responses emerge [22]. The TDF
domains identified, and the associated themed transcript
data assigned to them, will be reviewed by the second
coder to ensure an accurate representation of interview
content and to make a judgement about whether the
domains meet the criteria for importance (to retention of
trial participants) described above.
Initially, we will analyse data from each trial independently
so as to allow a nuanced understanding of the specific
barriers to retention to be produced. Findings across all
trials will then be compared and contrasted to identify areas
of both convergence and divergence for trials more generally
and also within and across trial participants and trial staff.
Forming possible solutions (RO3)
Research objectives 1 and 2 will generate the stakeholder
data required to inform development of the interven-
tions. Research objective 3 will begin to develop these
data into participant-centred, theoretically informed
interventions to minimise trial participant drop out.
Study design
Identifying intervention components to target barriers
and enablers to retention will involve using established
methods to map the key theoretical domains (identified
in RO2) to behaviour change techniques likely to be
effective in addressing those barriers and making use of
enablers [12–16]. Further development of the behaviour
change techniques into candidate retention interventions
will be generated through a co-production workshop,
which will be led by both researchers and PPI study
members.
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Mapping of theoretical domains to behaviour change
techniques
In brief, we will link the barriers and enablers reported
by trial stakeholders to retention-relevant domains of
the TDF (RO1 and RO2) which in turn will be used to
identify specific behaviour change techniques. This linking
of barriers and enablers to domains will be done through
the mapping process described by Michie et al. and use a
published mapping tool [27]. Three members of the
research team will map the relevant TDF domains to the
list of 93 BCTs [27]. Coders will independently score
whether each BCT could be used to target the TDF
domains using a scoring system (see Table 1). As before,
inter-rater reliability for coding will be assessed using
Cohen’s kappa, with a kappa value of 0.75 or more repre-
senting high agreement [25]. BCTs for which there is
agreed non-use will be excluded. The remaining BCTs will
be ranked by the total count of TDF domains for which
there was either ‘agreed use’ and those with the most
cross-over will be taken forward for further development.
During the mapping process, the informational content
(i.e. ‘what’ will be delivered) and possible modes of
delivery (i.e. ‘how’ the behaviour change technique will be
delivered) will be considered. Table 2 provides an example
of the steps used to choose behaviour change techniques
to overcome the barriers and enhance the enablers. The
table highlights the focus on ‘technique’, ‘mode’ and
‘content’ as the required elements of intervention develop-
ment. This process will identify techniques for inclusion
in candidate behavioural retention interventions to explore
further and prioritise with stakeholders.
Co-production workshop to develop candidate retention
interventions
Participant identification and recruitment To package
the behaviour change techniques as ‘interventions’, we
will invite trial non-retainers to participate in a co-
production exercise with members of the study team to
decide how best to deliver the techniques. By involving
trial non-retainers in the co-production of the behavioural
interventions we anticipate that the interventions will be
more likely to be deemed acceptable and further underpin
our participant-centred approach.
We will invite 12 participants (which may include
some of those from the interview study in A, and trial
non-retainers who were interested to be interviewed but
not-required due to sample being full) to participate in
the co-production exercise. We will seek expressions of
interest in this later stage of the study at the end of the
interviews in RO1 or through discussion with those who
indicated an interest in interviews but were not included
(due to not being required or a suitable time for inter-
view not being identified). We will obtain permission to
contact for future linked research during the verbal
consent discussion recorded for the interview study. If
an adequate number of non-retainers cannot be identi-
fied for the co-production activity, this group will be
supplemented with trial retainers. We will identify trial
retainers through the ongoing trials of the linked clinical
trials units (CTUs) whose participants have given previous
consent to be contacted about other research or through
known contacts of the STEER PPI representatives. We will
purposively sample participants so as to maximise diver-
sity but also to include those who will actively and
meaningfully engage in the process of co-production. We
will send invitation letters to potential participants (again
informed by the PPI members) outlining the next stage of
the research and asked to contact the STEER research
fellow (RN) or either of the PPI members directly if
interested in participating in the workshop. Written
consent will be sought on the day of the workshop before
data collection commences.
Data collection We will design a 1-day workshop with
focussed activities, such as demonstrations, role plays
and discussions (dependent on the BCTs identified and
how they might be incorporated into an intervention), to
explore possible options for intervention delivery based
on the potential techniques identified from phase B.2. A
summary of the findings to date will be generated (by
the STEER team) and disseminated to participants 2
weeks before the meeting. Members of the research
team (researchers and PPI members) will facilitate the
workshop to promote and encourage discussion and
observers to document main discussion points. Discussion
will be facilitated through a range of prompts and
informed by the Affordability; Practicability; Effectiveness
and cost-effectiveness; Acceptability; Side-effects and
safety; and Equity (APEASE) criteria [28]. The APEASE
criteria have been developed for designing and evaluating
interventions. The criteria consist of: affordability; practic-
ability; effectiveness and cost-effectiveness; acceptability;
side-effects and safety; and equity [28]. All discussions will
be audio-recorded where possible. In addition to interven-
tion delivery, if more than one intervention is presented to
Table 1 Scoring system for choosing potential behaviour change
techniques (BCTs) to include in intervention
Decision on inclusion Scoring for each BCTa
Agreed use Two or more raters scored with a 2 or 3,
except if the third rater scored a 0
Agreed non-use Two or more raters scored with a 0
Disagreement One rater scored with a 0 and two raters
scored with a 2 or 3
Uncertain All other cells in the matrix
aThree raters independently score each BCT as 0–3, where 0 = no, 1 = possibly,
2 = probably and 3 = definitely. Taken from Michie et al. [27]
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the co-production team, a prioritisation exercise (e.g.
ranking process) will be included. This will be operationa-
lised through the use of an anonymised rating system.
Data analysis We will summarise findings from the
workshop and we will agree key points (for each interven-
tion) with any areas of disagreement highlighted. A copy
of the findings (structured around the activities conducted
on the day of the workshop) will be sent back to workshop
participants for agreement or clarification with any
additional points being incorporated into the overall
findings. These findings will then be fed directly into RO4
of the project, preparing interventions for evaluation.
Evaluating feasibility and acceptability of the intervention
(RO4)
It is likely that many of the trials, for which the developed
interventions are applicable, will have outcomes that are
collected long after our proposed study ends. Whilst it is
unlikely that any of our interventions can be formally
evaluated for effectiveness within the timeframe of the
current study, an assessment of intervention acceptability
and feasibility will be conducted forming an initial
evaluation of the developed interventions. In addition, it is
critical that the main output from this work is the
provision, wide dissemination and initial small-scale
implementation of testable intervention packages that can
be adopted into ongoing trials, or trials in development.
To prepare the ground for rapid future testing of our
theory-based retention interventions, we will develop
SWAT (Studies Within A Trial) protocols [29]. By
developing interventions and presenting them as
SWATs, which provide a ready-to-use evaluation frame-
work for others, we will further support collaborative
efforts to reduce research waste [30]. Finally, we will
develop an explanatory retention framework, informed by
the study findings.
Study design
Intervention acceptability and implementation potential
Participant identification and recruitment
We will explore the acceptability of the interventions
and their potential for implementation in focus groups
with potential trial participants and trial staff. For the
purposes of this study, acceptability is defined as ‘the
extent to which people delivering or receiving a retention
intervention consider it to be appropriate, based on
anticipated or experiential cognitive and emotional
responses to the intervention’ (adapted from Sekhon et
al. 2017) [31]. Three focus groups are planned: one with
potential trial participants; one with trial staff; and an-
other with Research Ethics Committee (REC) members.
We will identify potential trial participants (n = 8–10)
through the Scottish Health Register for Research
(SHARE); we will identify trial staff through the UK
Clinical Research Collaboration-registered Clinical Trials
Units (CTUs) or UK Trial Managers Network. We will
identify REC members through the Health Research
Authority distribution lists for REC members. All groups
will be invited to participate in a focus group to explore
intervention acceptability and potential for implementation.
Prospective participants will be sent an invitation letter and
study information in the initial email sent from the register
or listserv gatekeeper. We will ask interested parties to
contact the STEER research fellow (RN) directly (by email)
to arrange a convenient time to conduct the focus group.
Before the focus group commences the researcher will
obtain informed consent, both written and verbal, from
participants.
Data collection
Discussions will open through presentation of the
interventions and will focus discussions on intervention
content, mode of delivery and contextual applicability.
We will develop the topic guide in collaboration with
the STEER PPI members and be informed by the
theoretical framework of acceptability (TFA). The TFA is
Table 2 Example of steps used to choose behaviour change techniques for retention interventions
Barriers and enablers that require addressing Within which theoretical
domains do the barriers
and enablers operate?
Which intervention components (behaviour change techniques)
could overcome the barriers and enhance the enablers?
Low awareness of the trial requirements (i.e. number
of follow-up questionnaires) amongst participants.
Knowledge Technique: Instruction on how to perform a behaviour
Mode: Patient Information Leaflet, recruitment consultation
Content: Explicit communication of all follow-up questionnaires
(providing personalised timeline of receipt), giving examples of
content
Drop out of trial as start to feel well and do not feel
the trial ‘monitoring’ (which may have motivated
initial participation) is required
Beliefs about consequences Technique: Salience of consequences
Mode: Telephone calls by trial team at key time points
Content: Explaining importance to trial overall of staying in.
Explain commitment to trial and why full commitment across
the timeline will maximise validity of trial findings, thereby
benefiting future patients
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composed of seven constructs: affective attitude, burden,
perceived effectiveness, ethicality, intervention coherence,
opportunity costs and self-efficacy [31]. Additional
questions about potential implementation, barriers and
enablers of, will also be included. The STEER research
fellow (RN) will facilitate the groups with note-taking and
facilitative support from two other members of the
research team (KG and a PPI member). The focus groups
will be scheduled to last for approximately 1.5 h. Focus
groups will be audio-recorded and transcribed. At the end
of each focus group we will provide participants with an
anonymous questionnaire and ask them to record their
extent of agreement with the expressed views of the majority
or to state anything that they were not able to voice in the
group. This will ensure that those participants who may have
disagreed with the majority in the group, but felt unable to
voice their disagreement, are given the opportunity to do so
(a method used in a previous study conducted by JF).
Data analysis
We will code and compare focus group data through a
process of constant comparison to provide a summary
of the key points about what stakeholders consider
important in terms of acceptability and feasibility. We will
pay particular attention to any themes arising de novo
from the data in addition to a priori-defined component
constructs of the TFA and with acknowledgment of the
APEASE criteria. We will explore data for confirmatory
and dis-confirmatory evidence to support the constructs
within the TFA and the APEASE criteria. We will import
the transcripts into NVivo and analysed using the
Framework approach, which is an established interpretive
approach that uses constant comparison techniques [32].
The codes identified, and the associated data assigned to
them, from the transcripts will be reviewed by a second
member of the project team. Specifically, the analysis will
be oriented to address the aim of exploring intervention
acceptability with particular attention being paid to
implementation of the intervention in practice. We will
analyse the data from the questionnaire separately but in a
similar method as that described above, paying particular
attention to any outliers. Any intervention modifications
proposed and agreed during the analysis will be incorpo-
rated and included in the SWAT protocols.
SWAT protocols SWAT protocols aim to be brief but
specify the requirements for execution of a nested RCT.
The SWATs designed in this project will follow existing
templates that include details on: background; intervention
and comparator; allocation; primary outcome(s); secondary
outcome(s); analysis; possible problems; resource require-
ments and version information [29]. In addition to these
pre-specified template headings, we will also incorporate
guidance on the more practical aspects of how to embed
studies on retention within trials, e.g. providing text to
help with ethical approval and considerations for ensuring
intervention fidelity. Further to this, the project team will
critically reflect on how any change in behaviour (i.e.
retention) will be measured and understood, i.e. outcomes
and mediators of retention (identified in RO2) and the
range of outcomes that may be appropriate for inclusion
in the SWAT protocols.
The four trials units represented in this bid alone
coordinate approximately 60 trials at any one time,
providing a large pool of trials for large-scale testing
(outside this proposal) of candidate retention interven-
tions. We will explore implementation of retention
SWATs into the procedures of these four trials units
during the course of this research – again with learning
likely transferable across other units and SWAT design
summaries. Each unit will aim to commit to building
one of our SWATs into at least one of its trials.
Explanatory retention framework In addition to the
SWATs and the exploratory pilot, a retention framework
will illustrate potential types of dropout and the context-
ual factors influencing dropout. This framework will
help trialists to identify and think through dropout is-
sues during the design and conduct phases of their trials
when they can adjust design, or build in interventions to
mitigate potential future problems. This will use the
findings from this research project, as well as from re-
cent methodological work on developing SWATs for re-
cruitment strategies and embedding recruitment studies
within RCTs [33].
Discussion
We believe this to be one of the first studies to apply a the-
oretical lens to the development of participant-centred in-
terventions to improve trial retention. By developing and
identifying priority interventions, exploring their acceptabil-
ity and planning for the evaluation of the interventions in
SWATs, this study further supports efforts to reduce re-
search waste [19]. We will track potential effects of trial di-
versity (e.g. context and trials unit factors) on intervention
appropriateness, although we envisage that the lessons from
this research will be transferable to other trial contexts.
Trial status
Trials methodology. All trials that will be involved will be on-
going. The project is registered at www.researchregistry.com
(researchregistry2831). A populated SPIRIT Checklist and
Figure are available as an additional file (Additional file 1).
Additional file
Additional file 1: SPIRIT 2013 Checklist completed for STEER Protocol.
(DOC 120 kb)
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